s 8921 has been researched along with uridine diphosphate glucuronic acid in 1 studies
| Studies (s 8921) | Trials (s 8921) | Recent Studies (post-2010) (s 8921) | Studies (uridine diphosphate glucuronic acid) | Trials (uridine diphosphate glucuronic acid) | Recent Studies (post-2010) (uridine diphosphate glucuronic acid) |
|---|---|---|---|---|---|
| 11 | 0 | 0 | 502 | 2 | 71 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, T; Hara, S; Horie, K; Kanazu, T; Kusuhara, H; Matsuo, Y; Miyata, K; Nomura, K; Okamura, N; Sakamoto, S; Shimaoka, H; Sugiyama, Y | 1 |
1 other study(ies) available for s 8921 and uridine diphosphate glucuronic acid
| Article | Year |
|---|---|
Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action.
Topics: Animals; Anticholesteremic Agents; Cell Line; Cells, Cultured; Cholesterol; Cholesterol, HDL; Glucuronosyltransferase; Hepatocytes; Humans; Hypercholesterolemia; Intestinal Absorption; Kinetics; Male; Molecular Structure; Naphthols; Organic Anion Transporters, Sodium-Dependent; Portal Vein; Rats; Rats, Gunn; Rats, Wistar; Symporters; Taurocholic Acid; Transfection; Uridine Diphosphate Glucuronic Acid | 2007 |